118 related articles for article (PubMed ID: 9241611)
1. Interferon immunogenicity: technical evaluation of interferon-alpha 2a.
Hochuli E
J Interferon Cytokine Res; 1997 Jul; 17 Suppl 1():S15-21. PubMed ID: 9241611
[TBL] [Abstract][Full Text] [Related]
2. Interferon immunogenicity: preclinical evaluation of interferon-alpha 2a.
Palleroni AV; Aglione A; Labow M; Brunda MJ; Pestka S; Sinigaglia F; Garotta G; Alsenz J; Braun A
J Interferon Cytokine Res; 1997 Jul; 17 Suppl 1():S23-7. PubMed ID: 9241612
[TBL] [Abstract][Full Text] [Related]
3. Development and use of enzyme-linked immunosorbent assays (ELISA) for the detection of protein aggregates in interferon-alpha (IFN-alpha) formulations.
Braun A; Alsenz J
Pharm Res; 1997 Oct; 14(10):1394-400. PubMed ID: 9358552
[TBL] [Abstract][Full Text] [Related]
4. Clinical investigation of the immunogenicity of interferon-alpha 2a.
Ryff JC
J Interferon Cytokine Res; 1997 Jul; 17 Suppl 1():S29-33. PubMed ID: 9241613
[TBL] [Abstract][Full Text] [Related]
5. Influence of bovine serum albumin on the secondary structure of interferon alpha 2b as determined by far UV circular dichroism spectropolarimetry.
Johnston MJ; Nemr K; Hefford MA
Biologicals; 2010 Mar; 38(2):314-20. PubMed ID: 20031446
[TBL] [Abstract][Full Text] [Related]
6. Distinct effect of pH 2 on a common antigenic structure found in human interferons-alpha 1 and -alpha 2 in the region 30-35.
Kontsek P; Borecký L; Novák M; Kontseková E; Máciková I; Krchnák V
J Interferon Res; 1991 Dec; 11(6):327-32. PubMed ID: 1724779
[TBL] [Abstract][Full Text] [Related]
7. Elimination of the free sulfhydryl group in the human serum albumin (HSA) moiety of human interferon-alpha2b and HSA fusion protein increases its stability against mechanical and thermal stresses.
Zhao HL; Xue C; Wang Y; Sun B; Yao XQ; Liu ZM
Eur J Pharm Biopharm; 2009 Jun; 72(2):405-11. PubMed ID: 19462475
[TBL] [Abstract][Full Text] [Related]
8. Increasing the homogeneity, stability and activity of human serum albumin and interferon-alpha2b fusion protein by linker engineering.
Zhao HL; Yao XQ; Xue C; Wang Y; Xiong XH; Liu ZM
Protein Expr Purif; 2008 Sep; 61(1):73-7. PubMed ID: 18541441
[TBL] [Abstract][Full Text] [Related]
9. Interferon (IFN)-alpha 2 genotype analysis of Chinese chronic hepatitis B patients undergoing recombinant IFN-alpha 2a therapy.
Crowe JS; Gewert DR; Barber KA; Lewis AP; Sims MJ; Davies SL; Salom CL; Wood J; Thomas HC; Thursz M
J Infect Dis; 1994 Apr; 169(4):875-8. PubMed ID: 8133104
[TBL] [Abstract][Full Text] [Related]
10. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
[TBL] [Abstract][Full Text] [Related]
11. Circumventing the heterogeneity and instability of human serum albumin-interferon-alpha2b fusion protein by altering its orientation.
Zhao HL; Xue C; Wang Y; Li XY; Xiong XH; Yao XQ; Liu ZM
J Biotechnol; 2007 Sep; 131(3):245-52. PubMed ID: 17698234
[TBL] [Abstract][Full Text] [Related]
12. Characterization of anti-interferon-alpha antibodies appearing during recombinant interferon-alpha 2a treatment.
Rönnblom LE; Janson ET; Perers A; Oberg KE; Alm GV
Clin Exp Immunol; 1992 Sep; 89(3):330-5. PubMed ID: 1516252
[TBL] [Abstract][Full Text] [Related]
13. Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha (IFN-alpha) in normal and transgenic mice.
Braun A; Kwee L; Labow MA; Alsenz J
Pharm Res; 1997 Oct; 14(10):1472-8. PubMed ID: 9358564
[TBL] [Abstract][Full Text] [Related]
14. High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG.
Ross C; Svenson M; Hansen MB; Vejlsgaard GL; Bendtzen K
J Clin Invest; 1995 May; 95(5):1974-8. PubMed ID: 7738163
[TBL] [Abstract][Full Text] [Related]
15. Anti-interferon antibodies to interferon-alpha 2b: results of comparative assays and clinical perspective.
Spiegel RJ; Jacobs SL; Treuhaft MW
J Interferon Res; 1989 Sep; 9 Suppl 1():S17-24. PubMed ID: 2553829
[TBL] [Abstract][Full Text] [Related]
16. Structure-function analysis of human IFN-alpha. Mapping of a conformational epitope by homologue scanning.
Wang L; Hertzog PJ; Galanis M; Overall ML; Waine GJ; Linnane AW
J Immunol; 1994 Jan; 152(2):705-15. PubMed ID: 7506733
[TBL] [Abstract][Full Text] [Related]
17. An Albumin-Free Formulation for Escherichia coli-Derived Interferon Beta-1b with Decreased Immunogenicity in Immune Tolerant Mice.
Abdolvahab MH; Fazeli A; Radmalekshahi M; Nejadnik MR; Fazeli MR; Schellekens H
J Interferon Cytokine Res; 2016 Mar; 36(3):192-203. PubMed ID: 26824268
[TBL] [Abstract][Full Text] [Related]
18. Thermal stability of the WHO international standard of interferon alpha 2b (IFN-alpha 2b): application of new reporter gene assay for IFN-alpha 2b potency determinations.
Caserman S; Menart V; Gaines Das R; Williams S; Meager A
J Immunol Methods; 2007 Jan; 319(1-2):6-12. PubMed ID: 17196611
[TBL] [Abstract][Full Text] [Related]
19. In vitro inhibition of interferon alpha-2a antiproliferative activity by antibodies developed during treatment for essential thrombocythaemia.
Catani L; Gugliotta L; Zauli G; Bagnara GP; Antonelli G; Belmonte MM; Vianelli N; Bonsi L; Brunelli MA; Tura S
Haematologica; 1992; 77(4):318-21. PubMed ID: 1427442
[TBL] [Abstract][Full Text] [Related]
20. Anti-alpha interferon immunization: safety and immunogenicity in asymptomatic HIV positive patients at high risk of disease progression.
Gringeri A; Santagostino E; Mannucci PM; Siracusano L; Marinoni A; Criscuolo M; Carcagno M; Fall LS; M'Bika JP; Bizzini B
Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):381-7. PubMed ID: 7580831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
